Company Overview
SCINAI IMMUNOTHERAPEUTICS LTD.
SCNIRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2022 FY
Net Income
-6M
2022 FY
Shares Outstanding
754M
2022 FY
EPS
-0.01USD
2022 FY
Company Information
SIC Code
2836
CIK Code
1611747
Exchange
Nasdaq
Location
IL